Methylglyoxal promotes oxidative stress and endothelial dysfunction

Pharmacological Research

Volumn 65, Issue 5, 2012, Pages 497-506

  Sena, Cristina M ^a,b   Matafome, Paulo ^a,b   Crisóstomo, Joana ^a,b   Rodrigues, Lisa ^a,b   Fernandes, Rosa ^b   Pereira, Paulo ^b   Seiça, Raquel M ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Endothelial dysfunction; Glycation; Goto Kakizaki rats; Methylglyoxal; Oxidative stress; Type 2 diabetes

Indexed keywords

3 NITROTYROSINE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; METHYLGLYOXAL; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; BIOAVAILABILITY; CARBOHYDRATE SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; GLYCATION; GOTO KAKIZAKI RAT; IMMUNOFLUORESCENCE; INFLAMMATION; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASODILATATION; WISTAR RAT;

ANIMALS; CELL ADHESION MOLECULES; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; GLYCOSYLATION END PRODUCTS, ADVANCED; INFLAMMATION; MALE; MICROFILAMENT PROTEINS; NITRIC OXIDE; OXIDATIVE STRESS; PHOSPHOPROTEINS; PYRUVALDEHYDE; RATS; RATS, WISTAR; RECEPTORS, IMMUNOLOGIC; VASODILATION;

EID: 84859788536     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2012.03.004     Document Type: Article

References (56)

1. Thornalley PJ. Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification: a role in pathogenesis and antiproliferative chemotherapy. Gen Pharmacol 1996;27:565-73. (Pubitemid 26233322)
2. Desai K, Wu L. Methylglyoxal and advanced glycation endproducts: new therapeutic horizons? Recent Pat Cardiovasc Drug Discov 2007;2:89-99. (Pubitemid 46957320)
3. Kalapos MP. The tandem of free radicals and methylglyoxal. Chem Biol Interact 2008;171:251-71.
4. Sassi-Gaha S, Loughlin DT, Kappler F, Schwartz ML, Su B, Tobia AM, et al. Two dicarbonyl compounds, 3-deoxyglucosone and methylglyoxal, differentially modulate dermal fibroblast. Matrix Biol 2010;29:127-34.
5. McLellan AC, Thornalley PJ, Benn J, Sonksen PH. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin Sci (Lond) 1994;87:21-9. (Pubitemid 24220267)
6. Wang H, Meng QH, Gordon JR, Khandwala H, Wu L. Proinflammatory and proapoptotic effects of methylglyoxal on neutrophils from patients with type 2 diabetes mellitus. Clin Biochem 2007;40:1232-9. (Pubitemid 47562425)
7. Fosmark DS, Torjesen PA, Kilhovd BK, Berg TJ, Sandvik L, Hanssen KF, et al. Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus. Metabolism 2006;55:232-6. (Pubitemid 43098992)
8. Mostafa AA, Randell EW, Vasdev SC, Gill VD, Han Y, Gadag V, et al. Plasma protein advanced glycation end products, carboxymethyl cysteine, and carboxyethyl cysteine, are elevated and related to nephropathy in patients with diabetes. Mol Cell Biochem 2007;302:35-42. (Pubitemid 47202318)
9. Brouwers O, Niessen PM, Haenen G, Miyata T, Brownlee M, Stehouwer CD, et al. Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress. Diabetologia 2010;53:989-1000.
10. Vasdev S, Ford CA, Longerich L, Parai S, Gadag V, Wadhawan S. Aldehyde induced hypertension in rats: prevention by N-acetyl cysteine. Artery 1998;23:10-36. (Pubitemid 30045665)
11. Sena CM, Nunes E, Louro T, Proença T, Fernandes R, Boarder MR, et al. Effects of α-lipoic acid on endothelial function in aged diabetic and high-fat fed rats. Br J Pharmacol 2008;153:894-906. (Pubitemid 351328927)
12. Sena CM, Louro T, Matafome P, Nunes E, Monteiro P, Seiça RM. Antioxidant and vascular effects of gliclazide in type 2 diabetic rats fed high-fat diet. Physiol Res 2009;58:203-9.
13. Miller FJ, Gutterman DD, Rios CD, Heistad DD, Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 1998;82:1298-305. (Pubitemid 28294749)
14. Sena CM, Matafome P, Louro T, Nunes E, Fernandes R, Seiça RM. Metformin restores endothelial function in aorta of diabetic rats. Br J Pharmacol 2011;163:424-37.
15. Desai KM, Chang T, Wang H, Banigesh A, Dhar A, Liu J, et al. Oxidative stress and aging: is methylglyoxal the hidden enemy? Can J Physiol Pharmacol 2010;88:273-84.
16. Oelze M, Mollnau H, Hoffmann N, Warnholtz A, Bodenschatz M, Smolenski A, et al. Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction. Circ Res 2000;87:999-1005.
17. Yan SF, Yan SD, Ramasamy R, Schmidt AM. Tempering the wrath of RAGE: an emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation. Ann Med 2009;41:408-22.
18. Piga R, Naito Y, Kokura S, Handa O, Yoshikawa T. Short-term high glucose exposure induces monocyte-endothelial cells adhesion and transmigration by increasing VCAM-1 and MCP-1 expression in human aortic endothelial cells. Atherosclerosis 2007;193:328-34. (Pubitemid 47058120)
19. Berlanga J, Cibrian D, Guillen I, Freyre F, Alba JS, Lopez-Saura P, et al. Methylglyoxal administration induces diabetes-like microvascular changes and perturbs the healing process of cutaneous wounds. Clin Sci (Lond) 2005;109:83-95. (Pubitemid 40943037)
20. Schalkwijk CG, van Bezu J, van der Schors RC, Uchida K, Stehouwer CD, van Hinsbergh VW. Heat-shock protein 27 is a major methylglyoxal-modified protein in endothelial cells. FEBS Lett 2006;580:1565-70. (Pubitemid 43290351)
21. Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008;57:1446-54.
22. Dhar A, Dhar I, Jiang B, Desai KM, Wu L. Chronic methylglyoxal infusion by minipump causes pancreatic beta-cell dysfunction and induces type 2 diabetes in Sprague-Dawley rats. Diabetes 2011;60:899-908.
23. Jia X, Wu L. Accumulation of endogenous methylglyoxal impaired insulin signaling in adipose tissue of fructose-fed rats. Mol Cell Biochem 2007;306:133-9. (Pubitemid 350001825)
24. Desai KM, Wu L. Free radical generation by methylglyoxal in tissues. Drug Metabol Drug Interact 2008;23:151-73. (Pubitemid 351669569)
25. Baynes JW, Thorpe SR. Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med 2000;28:1708-16. (Pubitemid 30628657)
26. Chang T, Wu L. Methylglyoxal, oxidative stress, and hypertension. Can J Physiol Pharmacol 2006;84:1229-38. (Pubitemid 46707370)
27. Kuhla B, Luth HJ, Haferburg D, Boeck K, Arendt T, Munch G. Methylglyoxal, glyoxal, and their detoxification in Alzheimer's disease. Ann N Y Acad Sci 2005;1043:211-6. (Pubitemid 41123908)
28. Cooke JP, Dzau VJ. Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 1997;48:489-509. (Pubitemid 27101848)
29. Mukohda M, Yamawaki H, Nomura H, Okada M, Hara Y. Methylglyoxal inhibits smooth muscle contraction in isolated blood vessels. J Pharm Sci 2009;109:305-10.
30. Mukohda M, Morita T, Okada M, Hara Y, Yamawaki H. Long-term 629 methylglyoxal treatment impairs smooth muscle contractility in organ-cultured rat mesenteric artery. Pharmacol Res 2012;65:91-9.
31. Ding H, Triggle CR. Endothelial dysfunction in diabetes: multiple targets for treatment. Pflugers Arch 2010;459:977-94.
32. Guo Q, Mori T, Jiang Y, Hu C, Osaki Y, Yoneki Y, et al. Methylglyoxal contributes to the development of insulin resistance and salt sensitivity in Sprague-Dawley rats. J Hypertens 2009;27:1664-71.
33. Chang T, Wang R, Olson DJH, Mousseau DD, Ross ARS, Wu L. Modification of Akt1 by methylglyoxal promotes the proliferation of vascular smooth muscle cells. FASEB J 2011;25:1746-57.
34. Chang T, Wang R, Wu L. Methylglyoxal-induced nitric oxide and peroxynitrite production in vascular smooth muscle cells. Free Radic Biol Med 2005;38:286-93. (Pubitemid 39656138)
35. Ahmed MU, Brinkmann Frye E, Degenhardt TP, Thorpe SR, Baynes JW. N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J 1997;324:565-70.
36. Forbes JM, Cooper ME, Thallas V, Burns WC, Thomas MC, Brammar GC, et al. Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. Diabetes 2002;51:3274-82. (Pubitemid 35246974)
37. Bucala R, Tracey KJ, Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 1991;87:432-8.
38. Rashid G, Benchetrit S, Fishman D, Bernheim J. Effect of advanced glycation end-products on gene expression and synthesis of TNF-alpha and endothelial nitric oxide synthase by endothelial cells. Kidney Int 2004;66:1099-106. (Pubitemid 39121015)
39. Rojas A, Romay S, Gonzalez D, Herrera B, Delgado R, Otero K. Regulation of endothelial nitric oxide synthase expression by albumin-derived advanced glycosylation end products. Circ Res 2000;86:E50-4.
40. Xu B, Chibber R, Ruggiero D, Kohner E, Ritter J, Ferro A. Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products. FASEB J 2003;17:1289-91.
41. Yamagishi S, Fujimori H, Yonekura H, Yamamoto Y, Yamamoto H. Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells. Diabetologia 1998;41:1435-41. (Pubitemid 28551614)
42. Quehenberger P, Bierhaus A, Fasching P, Muellner C, Klevesath M, Hong M, et al. Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells. Diabetes 2000;49:1561-70.
43. Bailey AJ. Molecular mechanisms of ageing in connective tissues. Mech Ageing Dev 2001;122:735-55. (Pubitemid 32378723)
44. Basta G, Schmidt AM, De Caterina R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 2004;63:582-92. (Pubitemid 39078671)
45. Kim YS, Kim BC, Song CY, Hong HK, Moon KC, Lee HS. Advanced glycosylation end products stimulate collagen mRNA synthesis in mesangial cells mediated by protein kinase C and transforming growth factor-beta. J Lab Clin Med 2001;138:59-68. (Pubitemid 32589202)
46. Weigensberg MJ, Goran MI. Type 2 diabetes in children and adolescents. Lancet 2009;373:1743-4.
47. Willett W, Manson J, Liu S. Glycemic index, glycemic load, and risk of type 2 diabetes. Am J Clin Nutr 2002;76:S274-80.
48. Soulis T, Thallas V, Youssef S, Gilbert RE, McWilliam BG, Murray-McIntosh RP, et al. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury. Diabetologia 1997;40:619-28. (Pubitemid 27288105)
49. Aso Y, Inukai T, Tayama K, Takemura Y. Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes. Acta Diabetol 2000;37:87-92. (Pubitemid 32009315)
50. Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 2006;114:597-605. (Pubitemid 44199649)
51. Susic D. Cross-link breakers as a new therapeutic approach to cardiovascular disease. Biochem Soc Trans 2007;35:853-6. (Pubitemid 350206381)
52. Cernes R, Zimlichman R, Shargorodsky M. Arterial elasticity in cardiovascular disease: focus on hypertension, metabolic syndrome and diabetes. Adv Cardiol 2008;45:65-81.
53. Dobler D, Ahmed N, Song L, Eboigbodin KE, Thornalley PJ. Increased dicarbonyl metabolism in endothelial cells in hyperglycaemia induces anoikis and impairs angiogenesis by RGD and GFOGER motif modification. Diabetes 2006;55:1961-9. (Pubitemid 44509968)
54. Duran-Jimenez B, Dobler D, Moffatt S, Rabbani N, Streuli CH, Thornalley PJ, et al. Advanced glycation end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes. Diabetes 2009;58:2893-903.
55. Lund T, Svindland A, Pepaj M, Jensen A-B, Berg JP, Kilhovd B, et al. Fibrin(ogen) may be an important target for methylglyoxal-derived AGE modification in elastic arteries. Diab Vasc Dis Res 2011;8:284-94.
56. Ledet T, Heickendorff L, Rasmussen LM. Pathology of macrovascular disease. Baillière's Clin Endocrinol Metab 1988;2:391-405. (Pubitemid 19031847)